Latest Breaking News On - Inc marker therapeutics - Page 1 : comparemela.com

Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies

Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJuan veraInvestorsdaniel kontoh boatengGeoffrey shouseMarker therapeutics incDrug administrationCity of hope national medical centerHope national medical centerGlobal summitHematologic malignanciesPrincipal investigatorPress releaseChief executive officerCompany sponsored phaseMarker therapeuticsInc marker therapeutics

Marker Therapeutics Reports Pre-Clinical Data of its MT-601 MultiTAA-Specific T Cell Product Candidate in Lymphoma Cells

Marker Therapeutics Reports Pre-Clinical Data of its MT-601 MultiTAA-Specific T Cell Product Candidate in Lymphoma Cells
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesErica smithJuanf veraMediacasey mcdonaldInvestorsdaniel kontoh boatengMarker therapeutics incInvestor relationsChief executive officerInvestigational new drugMarker therapeuticsInc marker therapeuticsLooking statementsthisPrivate securities litigation reform actDaniel kontoh boatengCasey mcdonald

Marker Therapeutics Awarded $2 Million Grant from U S FDA to Support Marker s Phase 2 ARTEMIS Trial of MT-401 in Post-Transplant AML

Marker Therapeutics Awarded $2 Million Grant from U S FDA to Support Marker s Phase 2 ARTEMIS Trial of MT-401 in Post-Transplant AML
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNeda safarzadehviceMythili koneruMarker therapeutics incDrug administrationProducts grants programWall streetOrphan products grantsOrphan drug designationOrphan productsChief medicalProducts grants programtheMarker therapeuticsInc marker therapeuticsLooking statementsthisPrivate securities litigation reform act

Marker Therapeutics (MRKR) Announces $2M FDA Grant to Support Phase 2 ARTEMIS Trial of MT-401

Marker Therapeutics (MRKR) Announces $2M FDA Grant to Support Phase 2 ARTEMIS Trial of MT-401
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Neda safarzadehviceMythili koneruMarker therapeutics incDrug administrationProducts grants programOrphan products grantsOrphan drug designationOrphan productsChief medicalProducts grants programtheMarker therapeuticsInc marker therapeuticsLooking statementsthisPrivate securities litigation reform actInvestor relations

Marker Therapeutics Announces FDA Clearance of IND for MT-601, the six-antigen targeted T Cell Therapy for the treatment of relapsed/refractory Non-Hodgkin Lymphoma

Marker Therapeutics Announces FDA Clearance of IND for MT-601, the six-antigen targeted T Cell Therapy for the treatment of relapsed/refractory Non-Hodgkin Lymphoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNeda safarzadehviceMythili koneruMediaamy bonannoPeterl hoangMarker therapeutics incCompany investigational new drugDrug administrationInvestigational new drugChief medicalChief executiveCompany sponsored phaseMarker therapeuticsInc marker therapeuticsLooking statements thisPrivate securities litigation reform act